Baltimore City adds $80M to opioid settlement funds from Teva Pharmaceuticals with $35M coming in by the end of the year and the remaining $45M by close of FY25.
Yesterday Mayor Brandon M. Scott and the City of Baltimore announced an $80M settlement with Teva Pharmaceuticals to resolve the City’s claims against Teva and its associated companies for their role in Baltimore’s devastating opioid epidemic. Teva will make an initial payment of $35M by year’s end and pay the remainder by July 1, 2025. This is the fourth settlement the City has completed bringing Baltimore’s total recovery in opioid settlements to $322.5M.
“The extraordinary amount of work put into this case by our outside counsel and our internal Law Department team has paid off for the City,” said City Solicitor Ebony Thompson.
Per the most recent agreement with Teva, the City will allocate $5M for education and outreach efforts about the 988 system, $3M to Penn North Recovery Center, and $2M to BMore Power. The remainder of the funds will go through the process detailed in Mayor Scott’s executive order of August 29, 2024, which outlined a comprehensive framework for the administration of opioid restitution funds, in order to fight the ongoing opioid epidemic in Baltimore at all levels. To date Baltimore City has reached separate agreements with Teva, Allergan, CVS, and Cardinal Health.
